Seaport Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Seaport Therapeutics, Inc. (SPTX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 12.23 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-03
- Seaport Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 12.23M shares, a 72.85% decline year-over-year.
- Seaport Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 36.27M shares, a 0.00% change year-over-year.
- Seaport Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 45.06M shares.
- Seaport Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 36.27M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month |
|---|---|---|
| 2026-06-30 | 12.23M shares 10-Q · filed 2026-08-03 | 12.23M shares 10-Q · filed 2026-08-03 |
| 2026-03-31 | 36.27M shares 10-Q · filed 2026-06-08 | |
| 2025-06-30 | 45.06M shares 10-Q · filed 2026-08-03 | 45.06M shares 10-Q · filed 2026-08-03 |
| 2025-03-31 | 36.27M shares 10-Q · filed 2026-06-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |